Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Maryland Stem Cell Research Commission Announces 42 Projects for Funding

The Maryland Stem Cell Research Commission has completed its evaluation of the 141 applications in response to its 3 official Requests for Applications (RFAs) during the FY10 funding cycle. The board of directors of the Maryland Technology Development Corporation (TEDCO) reviewed the Commission’s recommendations and approved 42 projects totaling $11.7 M in funding through the Maryland Stem Cell Research Fund (MSCRF) under the Maryland Stem Cell Research Act of 2006.

Grant proposals featuring for-profit and not-for-profit collaboration were favored this funding cycle per the Commission’s request for applications. A total of 12 collaborative projects will be funded featuring collaboration between Maryland universities and for-profit companies. Companies involved in the projects include Life Technologies (Invitrogen), Lonza Walkersville, Inc., Q Therapeutics, Advanced Cell Technology, Pfizer Inc., and Quality Biological. Other projects also include collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), and the University of Miami Lenard M. Miller School of Medicine.

FY10’s projects recommended for funding include:

  • 5 applications for RFA-MD-10-1 (Investigator-Initiated Research Grants) – These grants are designed for investigators with preliminary data supporting the grant application. These Investigator-Initiated Research Grants will be for up to $1 million of direct costs over a two-to-five year project.
  • 19 applications for RFA-MD-10-2 (Exploratory Research Grants) – These grants are designed for investigators who are new to the stem cell field and for new hypotheses, approaches, mechanisms or models that may differ from current thinking in the stem cell field, without any preliminary data supporting the application. These Exploratory Research Grants will be for up to $100,000 of direct costs per year, for up to two years. Preference was not given to collaborative projects in this funding category. 
  • 18 applications for RFA-MD-10-03 (Post-Doctoral Fellowship Research Grants) – These grants are designed for post-doctorial fellows who wish to conduct basic and/or transitional research on all types of human stem cells in Maryland. These Post-Doctoral Research Grants will be for up to $55,000 of direct, indirect and fringe benefits costs per year, for up to two years.